New dye could spare thousands from unnecessary lymph node removal

NCT ID NCT06868238

Recruiting now Symptom relief Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study looks at whether a special dye called Magtrace can help women with non-invasive breast cancer (DCIS) avoid an extra surgery to remove lymph nodes. Normally, women having a mastectomy get this lymph node surgery just in case cancer has spread, but it's often not needed. Magtrace stays in the lymph nodes for weeks, so doctors can wait for final lab results and only do the lymph node surgery if invasive cancer is actually found. About 30 adults with DCIS planning mastectomy will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Florida
RECRUITING

Gainesville, Florida, 32608, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DUCTAL CARCINOMA IN SITU